NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Launches New Product Designed to Boost Immune System

October 6, 2020 11:03:51

Grey Cloak Tech (OTC: GRCK), through its subsidiary BergaMet NA, has introduced Clinical IMMUNE(TM), a concentrated nutraceutical supplement formulated with naturally grown, heart-healthy Citrus Bergamot SuperFruit(TM), BetaVia(TM) Complete, and nine other powerful immune-boosting ingredients. The company is calling the product the No. 1 immune system defense for the body. Clinical IMMUNE contains natural ingredients, is GMO-free, and has been scientifically formulated to reduce upper respiratory symptoms, strengthen the body’s immune system, and maintain healthy blood sugar and blood pressure. The product also works to support a healthy cardiovascular system and address infectious conditions. Clinical IMMUNE offers two immune-building ingredients not found together in any other available product: Citrus Bergamot SuperFruit and BetaVia(r), an algae-sourced beta glucan proven to provide immune support. “We are excited to introduce Clinical IMMUNE, a truly unique product among all the immune products available in the market today,” said Grey Cloak Tech president Duke Pitts in the press release. “Consumers would have to take up to 22 pills a day to accomplish what Clinical IMMUNE does with just two pills. In addition, people could be spending up to $200 a month for the 11 key ingredients contained in Clinical IMMUNE, all for under $40 a month. Clinical IMMUNE is not only designed for today’s conditions but is incredible for enhancing immune defense against flu and colds. We believe Clinical IMMUNE will become part of a daily health routine and one of our largest-selling products for years to come.”

To view the full press release, visit

About Grey Cloak Tech Inc. 

Grey Cloak Tech, through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients, is engaged in proprietary research and development of natural plant-based formulations as well as sales and distribution of natural ingredient cardiovascular and neuro products. For more information, visit the company’s websites:, and

NOTE TO INVESTORS: The latest news and updates relating to GRCK are available in the company’s newsroom at

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

NetworkNewsWire is part of the InvestorBrandNetwork